JP2002507429A - 核酸導入ベクター、該ベクターを含有する組成物及びそれらの使用 - Google Patents

核酸導入ベクター、該ベクターを含有する組成物及びそれらの使用

Info

Publication number
JP2002507429A
JP2002507429A JP2000538027A JP2000538027A JP2002507429A JP 2002507429 A JP2002507429 A JP 2002507429A JP 2000538027 A JP2000538027 A JP 2000538027A JP 2000538027 A JP2000538027 A JP 2000538027A JP 2002507429 A JP2002507429 A JP 2002507429A
Authority
JP
Japan
Prior art keywords
sequence
nucleic acid
oligonucleotide
transfer vector
acid transfer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000538027A
Other languages
English (en)
Japanese (ja)
Inventor
シオリナ，カロル
シエルマン，ダニエル
ウイルス，ピエール
Original Assignee
アバンテイス・フアルマ・エス・アー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9803573A external-priority patent/FR2776669B1/fr
Application filed by アバンテイス・フアルマ・エス・アー filed Critical アバンテイス・フアルマ・エス・アー
Publication of JP2002507429A publication Critical patent/JP2002507429A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2000538027A 1998-03-24 1999-03-19 核酸導入ベクター、該ベクターを含有する組成物及びそれらの使用 Withdrawn JP2002507429A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9803573A FR2776669B1 (fr) 1998-03-24 1998-03-24 Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations
US8584898P 1998-05-18 1998-05-18
US98/03573 1998-05-18
US60/085,848 1998-05-18
PCT/FR1999/000643 WO1999049067A1 (fr) 1998-03-24 1999-03-19 Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations

Publications (1)

Publication Number Publication Date
JP2002507429A true JP2002507429A (ja) 2002-03-12

Family

ID=26234216

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000538027A Withdrawn JP2002507429A (ja) 1998-03-24 1999-03-19 核酸導入ベクター、該ベクターを含有する組成物及びそれらの使用

Country Status (12)

Country Link
EP (1) EP1066396A1 (zh)
JP (1) JP2002507429A (zh)
KR (1) KR20010074456A (zh)
CN (1) CN1292827A (zh)
AU (1) AU758406B2 (zh)
BR (1) BR9909044A (zh)
CA (1) CA2323831A1 (zh)
HU (1) HUP0102413A3 (zh)
IL (1) IL138624A0 (zh)
NO (1) NO20004648D0 (zh)
PL (1) PL342944A1 (zh)
WO (1) WO1999049067A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0111145B1 (pt) * 2000-05-26 2013-06-04 mÉtodos para purificar dna de filamento duplo a partir de uma soluÇço contendo o dna de filamento duplo misturado com outros componentes.
FR2871465B1 (fr) * 2004-06-15 2006-09-08 Centre Nat Rech Scient Cnrse Collections de composes tracables et leurs utilisations
US7943589B2 (en) 2005-06-03 2011-05-17 President And Fellows Of Harvard College siRNA microbicides for preventing and treating diseases
US7795380B2 (en) 2006-06-02 2010-09-14 University Of Iowa Research Foundation Compositions and methods for nucleic acid delivery
JP6995768B2 (ja) * 2016-03-07 2022-02-21 クイデル カーディオバスキュラー インコーポレイテッド 免疫アッセイ対照およびその使用
RU2731513C2 (ru) * 2018-12-21 2020-09-03 Селл энд Джин Терапи Лтд Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов NOS2, NOS3, VIP, KCNMA1, CGRP, для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-NOS2, или Escherichia coli SCS110-AF/VTvaf17-NOS3, или Escherichia coli SCS110-AF/VTvaf17-VIP, или Escherichia coli SCS110-AF/VTvaf17-KCNMA1, или Escherichia coli SCS110-AF/VTvaf17-CGRP, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020698A1 (en) * 1991-05-17 1992-11-26 Uab Research Foundation Sequence specific dna binding drugs
US5670347A (en) * 1994-05-11 1997-09-23 Amba Biosciences Llc Peptide-mediated gene transfer
FR2731014B1 (fr) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique

Also Published As

Publication number Publication date
CN1292827A (zh) 2001-04-25
PL342944A1 (en) 2001-07-16
HUP0102413A1 (hu) 2001-10-28
KR20010074456A (ko) 2001-08-04
CA2323831A1 (fr) 1999-09-30
AU758406B2 (en) 2003-03-20
IL138624A0 (en) 2001-10-31
BR9909044A (pt) 2000-12-05
HUP0102413A3 (en) 2003-09-29
NO20004648L (no) 2000-09-18
NO20004648D0 (no) 2000-09-18
EP1066396A1 (fr) 2001-01-10
AU3406200A (en) 2000-12-14
WO1999049067A1 (fr) 1999-09-30

Similar Documents

Publication Publication Date Title
US5945400A (en) Nucleic acid-containing composition, preparation and use thereof
EP0759694B1 (en) Method for in vivo delivery of therapeutic agents via liposomes
Wang et al. pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse.
Aronsohn et al. Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy
JP4275728B2 (ja) 核酸を含有する組成物、その製造および使用
AU2002255285B2 (en) Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription
JPH09508100A (ja) 核酸を含む組成物、調製および使用
JP2022516647A (ja) 非毒性ｃａｓ９酵素およびその用途
AU4674101A (en) Compositions for drug delivery
WO2003012050A2 (en) Mitochondrial genome replenishment
US20030143742A1 (en) Compositions for receptor/liposome mediated transfection and methods of using same
JP2003519241A (ja) 二層型鉱物粒子に取り込まれた核酸を含む組成物
US6153597A (en) Pharmaceutical composition useful for nucleic acid transfection, and use thereof
JP2002533088A (ja) 非病原性トランスフェクションベクター
JP2002507429A (ja) 核酸導入ベクター、該ベクターを含有する組成物及びそれらの使用
FR2776669A1 (fr) Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations
MXPA00009046A (en) Nucleic acid transfer vectors, compositions containing same and uses
CZ20003441A3 (cs) Vektory pro přenos nukleových kyselin, přípravky, které je obsahují a jejich použití
WO2023081687A1 (en) Modified guide rnas for gene editing
AU737314B2 (en) Nucleic acid containing composition, preparation and uses of same
EP0967289A1 (en) Improvements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor
US20040063922A1 (en) Methods and compositions for catalytic DNA exchange in a sequence specific manner
Teng Cellular uptake and effect of phosphorothioated antisense oligodeoxynucleotides against glucose transporter 1 and glucose transporter 5 on breast tumor MCF-7 cells
MXPA97006016A (en) Composition containing nucleic acids, preparation and use
MXPA98001920A (en) Pharmaceutical composition useful for the transfection of nucleic acids and its u

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20060606